Offerings // SAB Biotherapeutics, Inc.

SABSW offering history

Every offering-related filing in SAB Biotherapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 421 filings back to Dec 7, 2020.

Last executed offering

Mar 19, 2026

424B5 — priced deal (shares or notes)

Last registration (announced)

Dec 29, 2025

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Mar 19, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 17, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 7, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 29, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 12, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Sep 30, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 22, 2025	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Sep 2, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jul 21, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jan 26, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 28, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 20, 2023	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Nov 3, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Oct 2, 2023	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Aug 30, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Aug 21, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jul 31, 2023	AW →	WITHDRAWN	Registration withdrawn
Jun 21, 2023	RW →	WITHDRAWN	Registration withdrawn
May 17, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 9, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
May 9, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 1, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Mar 24, 2023	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Mar 7, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Feb 10, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 8, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 3, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Dec 12, 2022	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Nov 18, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Aug 23, 2022	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Aug 17, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 7, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 16, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 29, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 26, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 29, 2021	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 15, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 3, 2021	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Oct 28, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Sep 24, 2021	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital

SABSW offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full SABSW workspace →

SABSW offering FAQ

When did SABSW last execute an offering?

Per SEC filings, SAB Biotherapeutics, Inc.'s most recent priced offering document is a 424B5 filed 2026-03-19. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did SABSW last announce or register an offering?

The most recent registration is a S-3 filed 2025-12-29. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.